Accelerate Diagnostics Inc (AXDX.O)
AXDX.O on Consolidated Issue listed on NASDAQ Capital Market
8.04USD
1 Jul 2013
8.04USD
1 Jul 2013
Price Change (% chg)
$-0.08 (-0.99%)
$-0.08 (-0.99%)
Prev Close
$8.12
$8.12
Open
$8.23
$8.23
Day's High
$8.42
$8.42
Day's Low
$7.85
$7.85
Volume
93,471
93,471
Avg. Vol
94,149
94,149
52-wk High
$9.22
$9.22
52-wk Low
$2.70
$2.70
AXDX.O
About
Accelerate Diagnostics, Inc., formerly Accelr8 Technology Corporation, is focused on developing and commercializing instrumentation for the rapid identification and antibiotic susceptibility testing of infectious pathogens. The Company focuses on the development of a rapid diagnostic platform, the BACcel system, intended for... (more)
No analyst recommendations are available for AXDX.O.
Overall
| Beta: | 1.25 |
| Market Cap (Mil.): | $312.29 |
| Shares Outstanding (Mil.): | 38.84 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| AXDX.O | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 72.35 | 33.02 |
| EPS (TTM): | -0.55 | -- | -- |
| ROI: | -56.87 | 4.69 | 19.07 |
| ROE: | -59.32 | 9.78 | 20.00 |
Earnings vs. 
Estimates
No consensus analysis data available.
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
